SUBSCRIBE
SUBSCRIBE

Abbott Laboratories

NEWS
Job Trends
Abbott Shuttering California Plant, Terminating 144 Employees
January 8, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Abbott Will Not Pursue Deal to Acquire St. Jude Medical
August 27, 2015
 · 
2 min read
Job Trends
Boston Scientific Cuts 455 as It Closes Two Facilities; Abbott Terminates 244
August 14, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
AstraZeneca PLC Dives Deeper Into Personalized Medicine With Abbott, Montreal Heart Institute Deals
May 13, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Abbott May Be Hunting for M&A With Cash Reaped From Mylan’s Three-Way Tussle
May 8, 2015
 · 
6 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
How Abbott is Reaping Rewards From Teva’s Bid for Mylan
April 23, 2015
 · 
5 min read
The Pink Slip Valentine: Companies Making Job Cuts
Job Trends
The Pink Slip Valentine: Companies Making Job Cuts: Sanofi, InterMune, Abbott, Syngenta AG, GlaxoSmithKline, Amgen
February 13, 2015
 · 
12 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Policy
U.S. Justice Department Claims Omnicare, Inc. Received Kickbacks From Abbott Laboratories
December 23, 2014
 · 
2 min read
Biotech Bay
How Abbott Laboratories Used Silicon Valley’s Game Plan To Build A Better Medical Device
November 6, 2014
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
BioMidwest
Abbott Receives CE Mark Approval for Next-Generation TriClip™ Device, Offering New Innovations for Tricuspid Heart Valve Repair
April 8, 2021
 · 
4 min read
BioMidwest
Abbott’s XIENCE™ Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy (DAPT) for High Bleeding Risk Patients
April 6, 2021
 · 
3 min read
BioMidwest
Abbott Announces its Pandemic Defense Coalition: A Global Network of Expert Collaborators Designed To Help Prevent Future Pandemics, Currently Searching for COVID-19 Variants
March 11, 2021
 · 
6 min read
BioMidwest
Abbott Introduces NeuroSphere™ Virtual Clinic, First-of-its-Kind Remote Neuromodulation Patient-Care Technology in the U.S.
March 8, 2021
 · 
5 min read
BioMidwest
Abbott Receives FDA EUA for Laboratory PCR Assay That Detects and Differentiates SARS-CoV-2, Flu A, Flu B and RSV in One Test - and FDA EUA for Asymptomatic Usage of Alinity m COVID-19 Test
March 5, 2021
 · 
4 min read
BioMidwest
Abbott Researchers Find Rare Group of People With Controlled HIV Who Could Be a Key To Unlocking Cure
March 2, 2021
 · 
5 min read
BioMidwest
Abbott Declares 389th Consecutive Quarterly Dividend
February 19, 2021
 · 
1 min read
BioMidwest
Abbott’s Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab
January 26, 2021
 · 
9 min read
BioMidwest
Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip™ Device
January 20, 2021
 · 
6 min read
Policy
Abbott Agrees to Global Transcatheter Litigation Settlement with Edwards Lifesciences
July 13, 2020
 · 
1 min read
Load More